David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$602M |
| 2 |
Booking.com
BKNG
|
+$582M |
| 3 |
Walmart Inc
WMT
|
+$407M |
| 4 |
Visa
V
|
+$395M |
| 5 |
Johnson & Johnson
JNJ
|
+$335M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$483M |
| 2 |
Salesforce
CRM
|
+$380M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$364M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$336M |
| 5 |
Colgate-Palmolive
CL
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.49% |
| 2 | Consumer Discretionary | 9.18% |
| 3 | Healthcare | 8.57% |
| 4 | Financials | 8% |
| 5 | Industrials | 4.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
Prelude Therapeutics
PRLD
$526M
| $269K | ﹤0.01% |
47,249
-20,756
| -31% | -$127K |
|
3652
Standex International
SXI
$3.69B
| $269K | ﹤0.01% |
2,199
+200
| +10% | +$22.8K |
|
3653
Zegna
ZGN
$3.66B
| $269K | ﹤0.01% |
19,718
-24,328
| -55% | -$301K |
|
3654
Northwest Bancshares
NWBI
$2.24B
| $269K | ﹤0.01% |
+22,320
| New | +$303K |
|
3655
AMERISAFE
AMSF
$485M
| $267K | ﹤0.01% |
+5,454
| New | +$286K |
|
3656
Solid Power Inc Warrant
SLDPW
$5.87M
| $266K | ﹤0.01% |
604,873
| – | – |
|
3657
New Mountain Finance
NMFC
$719M
| $266K | ﹤0.01% |
21,857
-42,022
| -66% | -$529K |
|
3658
CALL
Herbalife
HLF
$1.35B
| $266K | ﹤0.01% |
16,500
-35,800
| -68% | -$633K |
|
3659
Five Point Holdings
FPH
$367M
| $265K | ﹤0.01% |
112,181
+7,200
| +7% | +$16.9K |
|
|
PSTX
3660
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $264K | ﹤0.01% |
85,629
-253,492
| -75% | -$1.52M |
|
3661
Enterprise Financial Services Corp
EFSC
$2.29B
| $263K | ﹤0.01% |
5,909
-1,696
| -22% | -$86.7K |
|
3662
Rocky Brands
RCKY
$338M
| $263K | ﹤0.01% |
11,404
-1,885
| -14% | -$51.2K |
|
3663
Passage Bio
PASG
$15.5M
| $263K | ﹤0.01% |
13,717
-4,421
| -24% | -$120K |
|
3664
Ball Corp
BALL
$17B
| $262K | ﹤0.01% |
4,754
-453,849
| -99% | -$25.2M |
|
|
EMKR
3665
DELISTED
Emcore Corp
EMKR
| $262K | ﹤0.01% |
22,782
-1,871
| -8% | -$22.8K |
|
3666
PMV Pharmaceuticals
PMVP
$69.5M
| $262K | ﹤0.01% |
54,857
+38,890
| +244% | +$274K |
|
3667
Cavco Industries
CVCO
$4.52B
| $261K | ﹤0.01% |
821
-990
| -55% | -$274K |
|
3668
Novartis
NVS
$304B
| $258K | ﹤0.01% |
2,800
-20,643
| -88% | -$1.8M |
|
3669
Adicet Bio
ACET
$84.3M
| $257K | ﹤0.01% |
+2,788
| New | +$350K |
|
3670
BJ's Restaurants
BJRI
$1.39B
| $257K | ﹤0.01% |
+8,811
| New | +$275K |
|
3671
Evolent Health
EVH
$553M
| $256K | ﹤0.01% |
7,888
-57,324
| -88% | -$1.81M |
|
3672
Diodes
DIOD
$4.28B
| $255K | ﹤0.01% |
2,754
-200
| -7% | -$17.9K |
|
3673
TriCo Bancshares
TCBK
$1.72B
| $255K | ﹤0.01% |
6,128
-3,078
| -33% | -$148K |
|
|
CMLS
3674
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $254K | ﹤0.01% |
68,884
+39,328
| +133% | +$221K |
|
3675
Sun Communities
SUI
$15.3B
| $252K | ﹤0.01% |
1,792
-13,317
| -88% | -$1.95M |
|
Similar funds
David Shaw's Q1 2023 Portfolio in Review
As of Q1 2023, David Shaw held 5,246 positions worth $93.4B, up 3.2% from $90.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $9.17B in Q1 2023, closing 860 positions and reducing 1,787 holdings. Its most notable exit was SVB Financial Group, an estimated $163M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in State Street Utilities Select Sector SPDR ETF worth $99.9M.
- David Shaw's largest Q1 2023 buy was State Street Utilities Select Sector SPDR ETF: 2,950,552 shares worth $99.9M.
- David Shaw added most to Charles Schwab in Q1 2023, an estimated $602M increase.
- David Shaw's biggest Q1 2023 reduction was Microsoft, cutting an estimated $483M.
- David Shaw fully exited SVB Financial Group in Q1 2023, selling an estimated $163M.
- David Shaw's ten largest holdings make up 11% of its $93.4B portfolio in Q1 2023.
- David Shaw opened 431 new positions and closed 860 in Q1 2023.
- David Shaw's portfolio value rose 3.2% quarter-over-quarter to $93.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.